The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AEGLEA BIOTHERAPEUTICS INC COM 00773J103 1,876 269,578 SH   SOLE 0 269,578 0 0
APOLLO ENDOSURGERY INC COM 03767D108 126 15,601 SH   SOLE 0 15,601 0 0
APPLE INC COM 037833100 27 200 SH   SOLE 0 200 0 0
BEAM THERAPEUTICS INC COM 07373V105 28,881 224,391 SH   SOLE 0 224,391 0 0
CODIAK BIOSCIENCES INC COM 192010106 15,697 847,108 SH   SOLE 0 847,108 0 0
ELLIOTT OPPORTUNITY II CORP COM G30092129 20,020 2,000,000 SH   SOLE 0 2,000,000 0 0
IMMATICS NV COM N44445109 8,097 697,431 SH   SOLE 0 697,431 0 0
LEXICON PHARMACEUTICALS INC COM 528872302 164 35,714 SH   SOLE 0 35,714 0 0
PIONEER NATURAL RESOURCES CO COM 723787107 594 3,656 SH   SOLE 0 3,656 0 0
PLX PHARMA INC COM 72942A107 865 62,673 SH   SOLE 0 62,673 0 0
PORTLAND GENERAL ELECTRIC CO COM 736508847 5 118 SH   SOLE 0 118 0 0
SOLITON INC COM 834251100 1,687 75,000 SH   SOLE 0 75,000 0 0
TAYSHA GENE THERAPIES INC COM 877619106 29,493 1,391,190 SH   SOLE 0 1,391,190 0 0
TEXAS INSTRUMENTS INC COM 882508104 6,154 32,000 SH   SOLE 0 32,000 0 0
TFF PHARMACEUTICALS INC COM 87241J104 212 22,066 SH   SOLE 0 22,066 0 0
UNITEDHEALTH GROUP INC COM 91324P102 10 25 SH   SOLE 0 25 0 0
VANGUARD TOTAL WORLD STOCK ETF ETFS 922042742 16,421 158,484 SH   SOLE 0 158,484 0 0
WEYERHAEUSER CO COM 962166104 34 1,000 SH   SOLE 0 1,000 0 0